ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
Healthcare
$12.82 +0.73%
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
52W Low $16.64High $23.21
Volume 0.65M
Average 1.06M
ADRX Common Stock Issued
Cash raised by issuing new shares.
No reported Common Stock Issued figures are available to summarize.
Common Stock Issued history
Currency unavailable · from the cash flow
No Common Stock Issued data reported for this period type.
Common Stock Issued vs competitors
How ADRX compares with its peers on the latest reported figures
ADRX Competitors
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $486.47M USD | +117.8% | +110.5% | 677.6% | |
| LTM Mar 2026 | $180.34M USD | +39.9% | +29.0% | 562.2% | |
| LTM Mar 2026 | $107.05M USD | -1.8% | — | — | |
| LTM Mar 2026 | $24.86M USD | -60.1% | -15.0% | 31.2% | |
| LTM Mar 2026 | $12.44M USD | — | +219.3% | 27.4% | |
| LTM Mar 2026 | $393K USD | -99.8% | -9.0% | 9.7% | |
| LTM Mar 2026 | €1.71K EUR | — | -83.3% | 0.0% | |
| LTM Mar 2026 | $911.01 USD | — | -93.4% | 0.1% | |
| FY2025 | $0 USD | — | — | 0.0% | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — | — |
| Peer median (excluding ADRX) | — | -1.8% | -9.0% | 18.6% | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Currency unavailable
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.